TY - CHAP M1 - Book, Section TI - Gastroesophageal Reflux Disease A1 - Prunty, Jeremy J. A1 - Prunty, Leesa M. A2 - Chisholm-Burns, Marie A. A2 - Schwinghammer, Terry L. A2 - Malone, Patrick M. A2 - Kolesar, Jill M. A2 - Bookstaver, P. Brandon A2 - Lee, Kelly C. PY - 2022 T2 - Pharmacotherapy Principles & Practice, 6e AB - LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Explain the underlying causes of gastroesophageal reflux disease (GERD).Understand the difference between typical, atypical, and alarm symptoms.Determine when diagnostic tests should be recommended based on the clinical presentation.Identify the desired therapeutic outcomes for patients with GERD.Recommend appropriate nonpharmacologic and pharmacologic interventions for patients with GERD.Educate patients on appropriate lifestyle modifications and drug therapy issues including adherence, adverse effects, and drug interactions.Formulate a monitoring plan to assess the effectiveness and safety of pharmacotherapy for GERD. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/11 UR - ppp.mhmedical.com/content.aspx?aid=1187008552 ER -